Tango Therapeutics, Inc.
NASDAQ:TNGX
3.1 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 66.385 | 59.968 | 142.745 | 28.381 | 22.889 |
| Short Term Investments
| 270.5 | 306.165 | 342.51 | 161.939 | 17.536 |
| Cash and Short Term Investments
| 336.885 | 366.133 | 485.255 | 190.32 | 40.425 |
| Net Receivables
| 0 | 2 | 2 | 2 | 0 |
| Inventory
| 0 | 0.567 | 0.567 | 0 | 0 |
| Other Current Assets
| 9.653 | 13.711 | 5.083 | 0.183 | 1.231 |
| Total Current Assets
| 346.538 | 375.272 | 492.338 | 193.632 | 41.656 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 53.416 | 57.77 | 6.086 | 11.303 | 11.829 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | -18.456 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 3.423 | 1.712 | 2.279 | 0 |
| Tax Assets
| 0 | 15.033 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.613 | 3.428 | 0.019 | 0.038 | 2.279 |
| Total Non-Current Assets
| 56.029 | 61.198 | 7.817 | 13.62 | 14.108 |
| Total Assets
| 402.567 | 436.47 | 500.155 | 207.252 | 55.764 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 2.785 | 4.453 | 3.226 | 1.841 | 0.67 |
| Short Term Debt
| 2.082 | 3.54 | 3.006 | 0.959 | 0.655 |
| Tax Payables
| 0 | 0.035 | 0.052 | 0 | 0 |
| Deferred Revenue
| 25.67 | 31.792 | 26.022 | 31.977 | 0 |
| Other Current Liabilities
| 15.401 | 15.725 | 8.384 | 6.14 | 24.526 |
| Total Current Liabilities
| 45.938 | 55.545 | 40.69 | 40.917 | 25.851 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 36.838 | 39.361 | 0 | 6.925 | 7.884 |
| Deferred Revenue Non-Current
| 66.683 | 92.088 | 114.718 | 120.805 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 15.033 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0.005 | 14.124 |
| Total Non-Current Liabilities
| 103.521 | 131.449 | 114.718 | 127.735 | 22.008 |
| Total Liabilities
| 149.459 | 186.994 | 155.408 | 168.652 | 47.859 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 55.7 |
| Common Stock
| 0.102 | 0.088 | 0.088 | 0.04 | 0.013 |
| Retained Earnings
| -371.256 | -269.512 | -161.336 | -103.101 | -51.129 |
| Accumulated Other Comprehensive Income/Loss
| 0.186 | -3.705 | -0.765 | 0.017 | 0.01 |
| Other Total Stockholders Equity
| 624.076 | 522.605 | 506.76 | 141.644 | 3.311 |
| Total Shareholders Equity
| 253.108 | 249.476 | 344.747 | 38.6 | 7.905 |
| Total Equity
| 253.108 | 249.476 | 344.747 | 38.6 | 7.905 |
| Total Liabilities & Shareholders Equity
| 402.567 | 436.47 | 500.155 | 207.252 | 55.764 |